Search results for "Respiratory disease"

showing 10 items of 278 documents

WITHDRAWN: Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Ac…

2017

Gerontologymedicine.medical_specialtybusiness.industryRespiratory diseaseAlternative medicinemedicine.disease03 medical and health sciences0302 clinical medicine030228 respiratory systemGeneral partnershipAction planmedicineGeneral Earth and Planetary Sciences030212 general & internal medicineHealthy ageingbusinessGeneral Environmental ScienceAlergologia Polska - Polish Journal of Allergology
researchProduct

Das neurogene Lungenödem

1997

Das Neurogene Lungenodem (NLE) ist eine seltene, aber immer lebensbedrohliche Komplikation bei Patienten mit ZNS-Lasionen. Ein NLE mus immer dann angenommen werden, wenn sich nach einer Schadigung des zentralen Nervensystems akut ein pulmonales Odem entwickelt und andere Ursachen fur die pulmonalen Veranderungen, wie z.B. Aspiration, primar myokardiales Versagen oder toxische Einwirkungen ausgeschlossen werden konnen. Die verschiedenen Atiologien haben alle ein gemeinsames Charakteristikum: es handelt sich um akute Erkrankungen, die plotzlich zu erhohtem intrazerebralem Druck (ICP) fuhren. Beschrieben ist das NLE bei Patienten mit Schadel-Hirn-Verletzungen, intrakraniellen Blutungen, Hirnin…

Gynecologymedicine.medical_specialtyNeurogenic pulmonary edemaAnesthesiology and Pain Medicinebusiness.industryLung diseaseEdemaRespiratory diseasemedicineGeneral Medicinemedicine.symptombusinessmedicine.diseaseDer Anaesthesist
researchProduct

Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases.

2021

Patients with pre-existing respiratory diseases in the setting of COVID-19 may have a greater risk of severe complications and even death.A retrospective, multicenter, cohort study with 5847 COVID-19 patients admitted to hospitals. Patients were separated in two groups, with/without previous lung disease. Evaluation of factors associated with survival and secondary composite end-point such as ICU admission and respiratory support, were explored.1,271 patients (22%) had a previous lung disease, mostly COPD. All-cause mortality occurred in 376 patients with lung disease (29.5%) and in 819 patients without (17.9%) (Previous lung disease is a risk factor for mortality in patients with COVID-19.…

HOPE-COVID-19 Health Outcome Predictive Evaluation for COVID-19Respiratory diseasesOriginal30-Day mortalityenfermedades respiratoriasACE2 angiotensin converting enzyme IIlaw.invention0302 clinical medicineCQ/HCQ chloroquine/hydroxychloroquinelawCOPDrespiratory diseasesPrognosisICU intensive care unitIntensive care unitSTROBE strengthening the reporting of observational studies in epidemiologypronósticomedicine.anatomical_structureEPOCCohort studyPulmonary and Respiratory Medicinemedicine.medical_specialty30-day mortalityRT-PCR real time reverse transcriptase-polymerase chain reactionSARS-CoV-2 severe acute respiratory syndrome coronavirus 2WHO World Health OrganizationMERS middle east respiratory syndrome03 medical and health sciencesInternal medicinemedicineCOPDCOVID-19 2019 novel coronavirusRisk factorIQR interquartile rangeLungmortalidad a 30 díasbusiness.industryFEV1 forced expiratory volume in one secondCOVID-19Retrospective cohort studymedicine.diseaseHR hazard ratioICS inhaled corticosteroidsCI confidence intervalCoronavirusCOPD chronic obstructive pulmonary disease030228 respiratory systemRespiratory failureILD interstitial lung diseaseMiddle East respiratory syndromeprognosisHFNC high flow nasal cannulabusiness
researchProduct

The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1?

2009

The definition of asthma has evolved from that of an episodic disease characterized by reversible airways constriction to a chronic inflammatory disease of the airways, with at least partially reversible airway constriction. Increasing evidence supports the notion that small and large airways play a central role in asthma pathophysiology with regard to inflammation, remodeling and symptoms. The contribution of the distal airways to the asthma phenotype carries implications for the delivery of inhaled medications to the appropriate areas of the lung and for the monitoring of the response to asthma treatment. Asthma control is evaluated on the basis of symptoms, lung function and exacerbation…

ImmunologyAnti-Inflammatory AgentsBronchiDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioAir trappingAdrenal Cortex HormonesForced Expiratory VolumemedicineHumansImmunology and AllergyRespiratory systemsmall airwayAsthmaLungbusiness.industryRespiratory diseaserespiratory systemasthmamedicine.diseaseRespiratory Function Testsrespiratory tract diseasesTreatment Outcomemedicine.anatomical_structureSpirometryImmunologyBronchoconstrictionmedicine.symptombusinessRespiratory tract
researchProduct

Auswirkungen der Sauerstoffinhalation auf die Hämodynamik bei chronischer thromboembolischer pulmonaler Hypertonie

1998

PURPOSE This study evaluates the haemodynamic effects of oxygen inhalation on pulmonary artery pressure and pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension. METHOD In 47 patients with chronic thromboembolic pulmonary hypertension haemodynamic parameters were measured before and after oxygen inhalation. RESULTS In moderately severe and severe pulmonary hypertension oxygen inhalation significantly reduced mean pulmonary artery pressure by about 11.1% and 4.6%, respectively. However, pulmonary vascular resistance was not significantly affected. Oxygen saturation improved and heart rate was reduced. Cardiac index decreased in severe pulmonary hyperte…

Inhalationbusiness.industryRespiratory diseaseCardiac indexmacromolecular substancesmedicine.diseasePulmonary hypertensionmedicine.anatomical_structureBlood pressureAnesthesiamedicine.arteryPulmonary arteryVascular resistancemedicineRadiology Nuclear Medicine and imagingbusinessOxygen saturation (medicine)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19)

2020

Abstract Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory disease, which can evolve into multi-organ failure (MOF), leading to death. Several biochemical alterations have been described in COVID-19 patients. To date, many biomarkers reflecting the main pathophysiological characteristics of the disease have been identified and associated with the risk of developing severe disease. Lymphopenia represents the hallmark of the disease, and it can be detected since the early stage of infection. Increased levels of several inflammatory biomarkers, including c-reactive protein, have been found in COVID-19 patients and associ…

Kidney DiseaseClinical BiochemistryMyocardial InfarctionMedicine (miscellaneous)Disease030204 cardiovascular system & hematologySeverity of Illness Index0302 clinical medicineBiomarkers Coronavirus Infection030212 general & internal medicinebiochemical alterationAged 80 and overHealth PolicyLiver DiseasesMusclesLiver DiseaseRespiratory diseaseBlood Coagulation DisordersWater-Electrolyte BalancePathophysiologyC-Reactive ProteinDisease ProgressionCytokinesbiomarkerMuscleKidney DiseasesLiver dysfunctionCoronavirus InfectionsHumanCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia Viralmacromolecular substances03 medical and health sciencesBetacoronavirusLymphopeniamedicineHumansCytokinePandemicsAgedInflammationBlood Coagulation DisorderBetacoronavirubusiness.industrySARS-CoV-2Biochemistry (medical)Public Health Environmental and Occupational HealthCOVID-19Biochemical biomarkersmedicine.diseaseImmunologyCytokine stormbusinesslaboratoryBiomarkers
researchProduct

Congenital pulmonary lymphangiectasia

1991

Lung DiseasesMalePulmonary and Respiratory Medicinemedicine.medical_specialtyPediatricsLymphangiectasisLungbusiness.industryRespiratory diseaseInfant NewbornMEDLINEInfantPulmonary Edemamedicine.diseaseSurgeryPleural Effusionmedicine.anatomical_structureCongenital Pulmonary LymphangiectasiaRecien nacidoPediatrics Perinatology and Child HealthmedicineHumansLymphangiectasisRespiratory InsufficiencybusinessPediatric Pulmonology
researchProduct

Contrast-enhanced MRI of the lung

2000

The lung has long been neglected by MR imaging. This is due to unique intrinsic difficulties: (1) signal loss due to cardiac pulsation and respiration; (2) susceptibility artifacts caused by multiple air-tissue interfaces; (3) low proton density. There are many MR strategies to overcome these problems. They consist of breath-hold imaging, respiratory and cardiac gating procedures, use of short repetition and echo times, increase of the relaxivity of existing spins by administration of intravenous contrast agents, and enrichment of spin density by hyperpolarized noble gases or oxygen. Improvements in scanner performance and frequent use of contrast media have increased the interest in MR ima…

Lung DiseasesMalemedicine.medical_specialtyLung NeoplasmsContrast MediaPerfusion scanningSensitivity and SpecificityVentilation/perfusion ratiomedicineHumansRadiology Nuclear Medicine and imagingVascular DiseasesNeoplasm StagingLungbusiness.industryRespiratory diseaseInterstitial lung diseaseGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingPulmonary embolismContrast mediumCarcinoma Bronchogenicmedicine.anatomical_structureBreathingFemaleRadiologyPulmonary EmbolismPulmonary VentilationbusinessMagnetic Resonance AngiographyEuropean Journal of Radiology
researchProduct

Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19

2021

Abstract Objective The aim of the study was to assess the role of midregional proadrenomedullin (MR-proADM) in patients with COVID-19. Methods We included 110 patients hospitalized for COVID-19. Biochemical biomarkers, including MR-proADM, were measured at admission. The association of plasma MR-proADM levels with COVID-19 severity, defined as a requirement for mechanical ventilation or in-hospital mortality, was evaluated. Results Patients showed increased levels of MR-proADM. In addition, MR-proADM was higher in patients who died during hospitalization than in patients who survived (median, 2.59 nmol/L; interquartile range, 2.3–2.95 vs median, 0.82 nmol/L; interquartile range, 0.57–1.03; …

Lung DiseasesMalemedicine.medical_specialtySciencemedicine.medical_treatmentMR-proADMClinical BiochemistryComorbidityLabmed/1010Severity of Illness IndexGastroenterologyAdrenomedullinInterquartile rangeInternal medicineSeverity of illnessmedicineHumansAspartate AminotransferasesProtein PrecursorsSurvival analysisAgedRetrospective StudiesMechanical ventilationReceiver operating characteristicbiologyInterleukin-6SARS-CoV-2business.industryPatient SelectionBiochemistry (medical)C-reactive proteinCOVID-19Alanine TransaminaseRetrospective cohort studyMiddle AgedPrognosisSurvival Analysisrespiratory diseaseC-Reactive ProteininflammationHypertensionbiology.proteinbiomarkerBiomarker (medicine)FemaleTriagebusinessBiomarkersAcademicSubjects/MED00690Laboratory Medicine
researchProduct

Distribution of mitochondrial chaperonins in lung cells

2011

Lungmedicine.anatomical_structureChaperonins Hsp10 Hsp60 lung respiratory diseases fibroblasts epithelial cellsSettore BIO/16 - Anatomia UmanaGeneticsmedicineDistribution (pharmacology)BiologyMolecular BiologyBiochemistryBiotechnologyChaperoninCell biologyThe FASEB Journal
researchProduct